These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3719629)

  • 21. Augmentation of natural killer cell activity after arterial embolization of renal carcinomas.
    Bakke A; Göthlin JH; Haukaas SA; Kalland T
    Cancer Res; 1982 Sep; 42(9):3880-3. PubMed ID: 7105048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Possible role of natural cytotoxicity in impairment of collagen catabolism in focal scleroderma].
    Prozorovskaia NN; Suchkova TN; Suchkov SV; Del'vig AA
    Vopr Med Khim; 1988; 34(1):95-100. PubMed ID: 3369133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethanol and natural killer cells. II. Stimulation of human natural killer activity by ethanol in vitro.
    Li F; Cook RT; Alber C; Rasmussen W; Stapleton JT; Ballas ZK
    Alcohol Clin Exp Res; 1997 Sep; 21(6):981-7. PubMed ID: 9309305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
    Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
    J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune system dysregulation in uremia.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Zingraff J; Jungers P; Chatenoud L
    Semin Nephrol; 1994 May; 14(3):253-60. PubMed ID: 8036360
    [No Abstract]   [Full Text] [Related]  

  • 26. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
    Steinhauer EH; Doyle AT; Reed J; Kadish AS
    J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the mechanism of defective natural killer cytotoxicity in patients with multiple myeloma].
    Funato T; Koide A; Ohtani H; Saito M
    Gan No Rinsho; 1984 Apr; 30(4):368-72. PubMed ID: 6727037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of a moderate exercise training on natural killer cytotoxicity and personality traits in cancer patients.
    Peters C; Lötzerich H; Niemeier B; Schüle K; Uhlenbruck G
    Anticancer Res; 1994; 14(3A):1033-6. PubMed ID: 8074446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early recurrence of gastric cancer in a patient with chronic renal failure.
    Endo K; Baba H; Ohno S; Yamamoto M; Maehara Y; Sugimachi K
    Anticancer Res; 1995; 15(2):623-5. PubMed ID: 7763047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T lymphocyte subpopulations in chronic renal failure.
    Hou JS; Ma JM; Feng HF; Zuo JN; Cheng WY; Zhu X; Huang JW; Xu WZ; Gu HD; Zhu BF
    Chin Med J (Engl); 1986 Apr; 99(4):321-2. PubMed ID: 3098513
    [No Abstract]   [Full Text] [Related]  

  • 31. Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients.
    Gascon A; Orfao A; Lerma JL; Ciudad J; Lopez A; Hernandez MD; Tabernero JM
    Am J Kidney Dis; 1996 Mar; 27(3):373-9. PubMed ID: 8604706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [NK activity in the peripheral blood of patients with progressive polyarthritis. I. Correlation with clinical indicators].
    Strejcek J; Jíra M; Horký J; Antosová E
    Cas Lek Cesk; 1985 Nov; 124(47):1451-4. PubMed ID: 4064095
    [No Abstract]   [Full Text] [Related]  

  • 33. Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.
    Ginsburg CH; Dambrauskas JT; Ault KA; Falchuk ZM
    Gastroenterology; 1983 Oct; 85(4):846-51. PubMed ID: 6884709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
    Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distal procto-colitis, natural cytotoxicity, and essential fatty acids.
    Almallah YZ; Richardson S; O'Hanrahan T; Mowat NA; Brunt PW; Sinclair TS; Ewen S; Heys SD; Eremin O
    Am J Gastroenterol; 1998 May; 93(5):804-9. PubMed ID: 9625132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E.
    Srivastava R; Aggarwal R; Bhagat MR; Chowdhury A; Naik S
    J Viral Hepat; 2008 Dec; 15(12):910-6. PubMed ID: 18673427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
    Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
    Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation.
    Arbour S; Toupin S; Bélanger R; Gyger M; Hallé JP; Perreault C; Roy DC
    Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytotoxic activity of lymphocytes originating from chronic haemodialysis patients (author's transl)].
    Matsuo S; Ohkura T; Sakamoto N; Tamaki S; Kumon S; Hibi I
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):307-14. PubMed ID: 7382170
    [No Abstract]   [Full Text] [Related]  

  • 40. [Natural killer cell count in hemodialysis patients].
    Liszka M; Zukowska-Szczechowska E; Grzeszczak W; Moczulski D; Religa Z
    Pol Arch Med Wewn; 1998 Jul; 100(1):9-18. PubMed ID: 10085709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.